CREARE LLC — Department of Defense SBIR Phase I: DHA173-003

Description

Vascular access is among the first and most critical steps in the stabilization and treatment of critically injured soldiers and civilians. In the field, where patients are volume-depleted from blood loss or dehydration, vasoconstricted, or hypothermic, traditional peripheral venous access and CVC access becomes exceedingly difficult. We propose a self-contained device that significantly simplifies the cannulation process by reliably and rapidly automating vascular access. Our approach leverages an array of Creare-developed technologies and off the shelf products to form an integrated system. In Phase I, we will develop a preliminary design for a prototype system and demonstrate overall feasibility.In Phase II, we will develop a prototype system and will evaluate its effectiveness. In Phase III, we will validate the technology through clinical trials and will use that data to obtain FDA clearance.